Researchers sought to identify factors that quantify health-related quality of life for colorectal cancer survivors.
Researchers sought to determine the effect of caregivers’ emotions and distress on outcomes for patients with colorectal cancer.
The decrease in prostate cancer screening rates was the smallest among 5 cancers studied.
The approval is supported by data from the phase 3 BEACON CRC trial in adults with BRAF V600E mutation-positive metastatic colorectal cancer with disease progression.
A comparison of data from 2 studies on peripheral neuropathy found that CRC survivors would benefit from education related to recognizing early symptoms.